MARKET WIRECNBC • 2h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why PSNL Stock slipped -0.47% Today — RQD Quant Desk Flash
$15.93 -0.47% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $15.89
Personalis Inc. (PSNL) carries a Roarable Rating of D- (Sell) with 36/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $1.70B
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $15.89 (-0.27%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (36/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.3% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D
Each axis scored 0–20
12M PRICE TARGET CONE-9.9% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PSNL)Realized 20D OHLCV Swing Band: ±4.4%
Deterministic 5-Pillar Attribution (36/100 Composite)
🔍 WHY PSNL SCORES 36/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Macro Regime Fit+10/20 pts (28% of score)
FRED Regime × Technicals: 79% of 52W Range • RSI-14 at 45.2 (NEUTRAL RANGE)
▲ #2 Bullish Driver: Whale & Options Positioning+9/20 pts (25% of score)
20D Institutional Volume Accumulation (±4.4% realized swing band)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$16.00-2.2% Next Q
44
Q2 (-2Q)Grade D$15.65+1.3% Next Q
41
Q3 (-1Q)Grade E$15.85+0.5% Next Q
39
CurrentGrade D-$15.93-8.3% Hist 90D α
36
Trajectory: D (44) → D- (36)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a PSNL Turnaround Squeeze
While PSNL currently carries a cautious 36/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($16.34) and Max Pain ($16.73) forces dealer call-delta covering toward $19.83.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $PSNL• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “PSNL Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why PSNL Stock slipped -0.47% Today — RQD Quant Desk Flash
Personalis Inc. (PSNL) slipped -0.47% to $15.93, trading at 79% of its 52-week range ($4.96 – $18.89). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 79% of its 52-week range ($4.96 – $18.89) with RSI-14 at 45.2 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±4.4% around $15.93 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 22.7% gross margin and $0 annual free cash flow.
Live PSNL Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PSNL)
- ✓Walkthrough of PSNL's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
PSNL // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +188.59%▼ SUPPORT BREAKDOWN
2026-10-30O $15.86H $15.94L $15.65C $15.93VOL 2.36M
RES: $15.95SUP: $16.22SMA50: $16.34SMA200: $11.29
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
PSNL Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. -17.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on PSNL today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for PSNL. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for PSNL today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PSNL)
Health Care Rank #774 of 1016
⚔️ ALHC vs PSNL Full Matrix →
1. Head-to-Head Health Care Peer Comparison (PSNL vs. ALHC, FRNM, TRUP, FTRE)
Industry: Medical Specialities (41 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Personalis Inc. (PSNL) ranks #774 by composite RQD confidence (36/100, grade D-) and #286 by equity capitalization ($1.70B). Within this direct 5-issuer industry benchmark cohort, TRUP leads on earnings valuation at 68.2x trailing P/E, while ALHC leads on capital efficiency and profitability with 13.9% ROIC and — gross margin. ALHC currently holds the highest overall quantitative score in the immediate peer group at 67/100 (C+) compared with PSNL at 36/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| PSNL
ACTIVE
Personalis Inc. | D- | 36/100 | — | 22.7% | -35.0% | -0.47% | $1.70B | Benchmark Subject |
| ALHC Alignment Healthcare Inc. | C+ | 67/100 | — | — | 13.9% | -1.47% | $1.67B | /alhc-vs-psnl → |
| FRNM Freenome Inc. | E | 31/100 | — | — | -3.4% | -4.32% | $1.38B | /frnm-vs-psnl → |
| TRUP Trupanion Inc. | C | 64/100 | 68.2x | 16.1% | 3.1% | +2.27% | $1.32B | /trup-vs-psnl → |
| FTRE Fortrea Holdings Inc. | D- | 35/100 | — | — | -35.0% | -10.61% | $2.20B | /ftre-vs-psnl → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001527753In its most recent audited fiscal period (FY2025, filed 2025-12-31), Personalis Inc. (PSNL) reported GAAP revenue of $69.6M (-17.7% vs. FY2024 revenue of $84.6M , and -5.2% cumulative change since FY2023) , GAAP net income of -$81.3M, operating cash flow of -$74.9M, and free cash flow of -$79.5M (-69.9% YoY). On the balance sheet, PSNL closed FY2025 with $334.2M in total assets against $0 in total debt (Altman Z-Score: 11.50, Piotroski F-Score: 3/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $69.6M | -$81.3M | -$74.9M | -$79.5M | $334.2M | — |
| FY2024 (FY) | 2024-12-31 | $84.6M | -$81.3M | -$45.1M | -$46.8M | $270.3M | — |
| FY2023 (FY) | 2023-12-31 | $73.5M | -$108.3M | -$56.3M | -$56.3M | — | — |
3. PSNL Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs PSNL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Personalis Inc. (NASDAQ: PSNL) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 36/100 at a spot price of $15.93 (-0.47% 1D, market cap $1.70B). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, PSNL ranks #774 in composite RQD confidence.
How does PSNL compare to ALHC and FRNM in the Health Care sector?
Within the Health Care sector (Medical Specialities), PSNL carries a Roarable D- (36/100 RQD), trailing P/E of N/A, gross margin of 22.7%, and ROIC of -35.0%. By comparison, ALHC (Alignment Healthcare Inc.) holds a C+ grade (67/100 RQD, P/E N/A, ROIC 13.9%, cap $1.67B) and FRNM (Freenome Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC -3.4%, cap $1.38B). Among the 5-stock peer group, TRUP leads on earnings multiple (68.2x) while ALHC leads on capital efficiency (13.9% ROIC).
What are the biggest fundamental strengths and SEC risk factors for PSNL?
Per PSNL's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001527753), Personalis Inc. generated $69.6M in revenue (-17.7% YoY), -$81.3M in net income, and -$79.5M in free cash flow against $334.2M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is PSNL trading relative to its 50-day, 200-day, and 52-week technical levels?
PSNL last traded at $15.93 (-0.47% on volume of 749,266 shares), positioning the stock -2.51% below its 50-day simple moving average ($16.34) and +41.10% above its 200-day simple moving average ($11.29). Across its 52-week range of $4.96 to $18.89, PSNL sits at the 78.8% percentile with a 14-day RSI of 45.2 (NEUTRAL RANGE) and an implied next-earnings move of ±4.4% ($15.23 to $16.63).
PSNL Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is PSNL stock moving today?
Why PSNL Stock slipped -0.47% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.